Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules

Anil Vachani, Zane Hammoud, Steven Springmeyer, Neri Cohen, Dao Nguyen, Christina Williamson, Sandra Starnes, Stephen Hunsucker, Scott Law, Xiao Jun Li, Alexander Porter, Paul Kearney

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Evaluation of indeterminate pulmonary nodules is a complex challenge. Most are benign but frequently undergo invasive and costly procedures to rule out malignancy. A plasma protein classifier was developed that identifies likely benign nodules that can be triaged to CT surveillance to avoid unnecessary invasive procedures. The clinical utility of this classifier was assessed in a prospective–retrospective analysis of a study enrolling 475 patients with nodules 8–30 mm in diameter who had an invasive procedure to confirm diagnosis at 12 sites. Using this classifier, 32.0 % (CI 19.5–46.7) of surgeries and 31.8 % (CI 20.9–44.4) of invasive procedures (biopsy and/or surgery) on benign nodules could have been avoided. Patients with malignancy triaged to CT surveillance by the classifier would have been 24.0 % (CI 19.2–29.4). This rate is similar to that described in clinical practices (24.5 % CI 16.2–34.4). This study demonstrates the clinical utility of a non-invasive blood test for pulmonary nodules.

Original languageEnglish (US)
Pages (from-to)1023-1027
Number of pages5
JournalLung
Volume193
Issue number6
DOIs
StatePublished - Dec 1 2015

Fingerprint

Blood Proteins
Lung
Unnecessary Procedures
Hematologic Tests
Neoplasms
Biopsy
Clinical Studies

Keywords

  • Biomarker
  • Clinical utility
  • Lung cancer
  • Lung nodule
  • Prospective
  • Xpresys lung

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Vachani, A., Hammoud, Z., Springmeyer, S., Cohen, N., Nguyen, D., Williamson, C., ... Kearney, P. (2015). Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules. Lung, 193(6), 1023-1027. https://doi.org/10.1007/s00408-015-9800-0

Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules. / Vachani, Anil; Hammoud, Zane; Springmeyer, Steven; Cohen, Neri; Nguyen, Dao; Williamson, Christina; Starnes, Sandra; Hunsucker, Stephen; Law, Scott; Li, Xiao Jun; Porter, Alexander; Kearney, Paul.

In: Lung, Vol. 193, No. 6, 01.12.2015, p. 1023-1027.

Research output: Contribution to journalArticle

Vachani, A, Hammoud, Z, Springmeyer, S, Cohen, N, Nguyen, D, Williamson, C, Starnes, S, Hunsucker, S, Law, S, Li, XJ, Porter, A & Kearney, P 2015, 'Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules', Lung, vol. 193, no. 6, pp. 1023-1027. https://doi.org/10.1007/s00408-015-9800-0
Vachani A, Hammoud Z, Springmeyer S, Cohen N, Nguyen D, Williamson C et al. Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules. Lung. 2015 Dec 1;193(6):1023-1027. https://doi.org/10.1007/s00408-015-9800-0
Vachani, Anil ; Hammoud, Zane ; Springmeyer, Steven ; Cohen, Neri ; Nguyen, Dao ; Williamson, Christina ; Starnes, Sandra ; Hunsucker, Stephen ; Law, Scott ; Li, Xiao Jun ; Porter, Alexander ; Kearney, Paul. / Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules. In: Lung. 2015 ; Vol. 193, No. 6. pp. 1023-1027.
@article{a2a4bf8a40ee44418587425f8580f249,
title = "Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules",
abstract = "Evaluation of indeterminate pulmonary nodules is a complex challenge. Most are benign but frequently undergo invasive and costly procedures to rule out malignancy. A plasma protein classifier was developed that identifies likely benign nodules that can be triaged to CT surveillance to avoid unnecessary invasive procedures. The clinical utility of this classifier was assessed in a prospective–retrospective analysis of a study enrolling 475 patients with nodules 8–30 mm in diameter who had an invasive procedure to confirm diagnosis at 12 sites. Using this classifier, 32.0 {\%} (CI 19.5–46.7) of surgeries and 31.8 {\%} (CI 20.9–44.4) of invasive procedures (biopsy and/or surgery) on benign nodules could have been avoided. Patients with malignancy triaged to CT surveillance by the classifier would have been 24.0 {\%} (CI 19.2–29.4). This rate is similar to that described in clinical practices (24.5 {\%} CI 16.2–34.4). This study demonstrates the clinical utility of a non-invasive blood test for pulmonary nodules.",
keywords = "Biomarker, Clinical utility, Lung cancer, Lung nodule, Prospective, Xpresys lung",
author = "Anil Vachani and Zane Hammoud and Steven Springmeyer and Neri Cohen and Dao Nguyen and Christina Williamson and Sandra Starnes and Stephen Hunsucker and Scott Law and Li, {Xiao Jun} and Alexander Porter and Paul Kearney",
year = "2015",
month = "12",
day = "1",
doi = "10.1007/s00408-015-9800-0",
language = "English (US)",
volume = "193",
pages = "1023--1027",
journal = "Lung",
issn = "0341-2040",
publisher = "Springer New York",
number = "6",

}

TY - JOUR

T1 - Clinical Utility of a Plasma Protein Classifier for Indeterminate Lung Nodules

AU - Vachani, Anil

AU - Hammoud, Zane

AU - Springmeyer, Steven

AU - Cohen, Neri

AU - Nguyen, Dao

AU - Williamson, Christina

AU - Starnes, Sandra

AU - Hunsucker, Stephen

AU - Law, Scott

AU - Li, Xiao Jun

AU - Porter, Alexander

AU - Kearney, Paul

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Evaluation of indeterminate pulmonary nodules is a complex challenge. Most are benign but frequently undergo invasive and costly procedures to rule out malignancy. A plasma protein classifier was developed that identifies likely benign nodules that can be triaged to CT surveillance to avoid unnecessary invasive procedures. The clinical utility of this classifier was assessed in a prospective–retrospective analysis of a study enrolling 475 patients with nodules 8–30 mm in diameter who had an invasive procedure to confirm diagnosis at 12 sites. Using this classifier, 32.0 % (CI 19.5–46.7) of surgeries and 31.8 % (CI 20.9–44.4) of invasive procedures (biopsy and/or surgery) on benign nodules could have been avoided. Patients with malignancy triaged to CT surveillance by the classifier would have been 24.0 % (CI 19.2–29.4). This rate is similar to that described in clinical practices (24.5 % CI 16.2–34.4). This study demonstrates the clinical utility of a non-invasive blood test for pulmonary nodules.

AB - Evaluation of indeterminate pulmonary nodules is a complex challenge. Most are benign but frequently undergo invasive and costly procedures to rule out malignancy. A plasma protein classifier was developed that identifies likely benign nodules that can be triaged to CT surveillance to avoid unnecessary invasive procedures. The clinical utility of this classifier was assessed in a prospective–retrospective analysis of a study enrolling 475 patients with nodules 8–30 mm in diameter who had an invasive procedure to confirm diagnosis at 12 sites. Using this classifier, 32.0 % (CI 19.5–46.7) of surgeries and 31.8 % (CI 20.9–44.4) of invasive procedures (biopsy and/or surgery) on benign nodules could have been avoided. Patients with malignancy triaged to CT surveillance by the classifier would have been 24.0 % (CI 19.2–29.4). This rate is similar to that described in clinical practices (24.5 % CI 16.2–34.4). This study demonstrates the clinical utility of a non-invasive blood test for pulmonary nodules.

KW - Biomarker

KW - Clinical utility

KW - Lung cancer

KW - Lung nodule

KW - Prospective

KW - Xpresys lung

UR - http://www.scopus.com/inward/record.url?scp=84947485055&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84947485055&partnerID=8YFLogxK

U2 - 10.1007/s00408-015-9800-0

DO - 10.1007/s00408-015-9800-0

M3 - Article

VL - 193

SP - 1023

EP - 1027

JO - Lung

JF - Lung

SN - 0341-2040

IS - 6

ER -